Literature DB >> 26499003

Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!

Vipin M Vashishtha1, V G Ramachandran.   

Abstract

Live attenuated SA-14-14-2 vaccine against Japanese encephalitis (JE) was introduced in the routine immunization under Universal Immunization Program in the 181 endemic districts of India. Recently, the Government of India has announced the introduction of one dose of JE vaccine for adults in endemic districts. The policy to mass vaccinate adults has raised several concerns that are discussed in this write-up. Apart from adult vaccination, the continuation of large scale JE vaccination program despite it being a very focal problem, and continued neglect of some other serious public health illnesses have also been highlighted. The issue of lack of authentic data on effectiveness of currently employed SA-14-14-2 JE vaccine has also been discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26499003     DOI: 10.1007/s13312-015-0728-5

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  9 in total

1.  Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha.

Authors:  Jaya S Kshatri; Matrujyoti Pattnaik; Goldi Badaik; Hari R Choudhary; Asit Mansingh; Sanghamitra Pati; Debdutta Bhattacharya
Journal:  J Family Med Prim Care       Date:  2022-05-14

2.  Health system preparedness & community participation in Japanese encephalitis/acute encephalitis syndrome (JE/AES) prevention in a tribal district of Odisha, India.

Authors:  Krushna Chandra Sahoo; Sapna Negi; Girish Chandra Dash; Rakesh Kumar Sahoo; Jaya Singh Kshatri; Sheetal Panda; Matrujyoti Pattanaik; Goldi Badaik; Sanghamitra Pati; Debdutta Bhattacharya
Journal:  Indian J Med Res       Date:  2021-03       Impact factor: 2.375

3.  Pigsties near dwellings as a potential risk factor for the prevalence of Japanese encephalitis virus in adult in Shanxi, China.

Authors:  Xiaojie Ren; Shihong Fu; Peifang Dai; Huanyu Wang; Yuanyuan Li; Xiaolong Li; Wenwen Lei; Xiaoyan Gao; Ying He; Zhi Lv; Jingxia Cheng; Guiqin Wang; Guodong Liang
Journal:  Infect Dis Poverty       Date:  2017-06-08       Impact factor: 4.520

4.  Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015.

Authors:  Tran Minh Quan; Tran Thi Nhu Thao; Nguyen Manh Duy; Tran Minh Nhat; Hannah Clapham
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

5.  Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007-2016: Implications for introduction of immunization.

Authors:  Kishor Kumar Paul; Hossain M S Sazzad; Mahmudur Rahman; Sharmin Sultana; M Jahangir Hossain; Jeremy P Ledermann; Paul Burns; Michael S Friedman; Meerjady S Flora; Marc Fischer; Susan Hills; Stephen P Luby; Emily S Gurley
Journal:  Int J Infect Dis       Date:  2020-07-25       Impact factor: 3.623

6.  Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain.

Authors:  Priyank Sinha; Sameer Kumar; Charu Chandra
Journal:  Eur J Oper Res       Date:  2021-03-20       Impact factor: 6.363

Review 7.  The Outbreaks of Acute Encephalitis Syndrome in Uttar Pradesh, India (1978-2020) and Its Effective Management: A Remarkable Public Health Success Story.

Authors:  Neha Srivastava; Hirawati Deval; Mahima Mittal; Rajni Kant; Vijay P Bondre
Journal:  Front Public Health       Date:  2022-02-09

Review 8.  Seroepidemiological Studies on Japanese Encephalitis: A Systematic Review.

Authors:  Nur Suhada Ramli; Norayuni Mohd Ismail; Na'eemah Zaini; Firdaus Hayati; Mohammad Saffree Jeffree; Syed Sharizman Syed Abdul Rahim; Mohd Rohaizat Hassan
Journal:  Oman Med J       Date:  2022-03-22

9.  Artificial MicroRNA-Mediated Inhibition of Japanese Encephalitis Virus Replication in Neuronal Cells.

Authors:  Himani Sharma; Aarti Tripathi; Bharti Kumari; Sudhanshu Vrati; Arup Banerjee
Journal:  Nucleic Acid Ther       Date:  2018-11-20       Impact factor: 5.486

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.